Fit man over 40 running outdoors to support heart health after 40
| |

Heart Health After 40: ApoB, Lp(a) & Blood Pressure Guide

Photo by Omar Ramadan on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated July 2026

Cardiovascular disease is still the leading cause of death in adults over 40, and the frustrating truth is that most of the people it kills had “normal” cholesterol on their last routine blood panel. Heart health after 40 isn’t about total cholesterol — it’s about three numbers most doctors still don’t measure by default: ApoB, Lp(a), and a blood pressure target that’s tighter than you probably think. This guide covers all three, explains what the research actually says, and gives you a practical protocol to act on this week.

Key Takeaways

  • ApoB is a more accurate predictor of cardiovascular risk than LDL cholesterol, and optimal levels for longevity are likely below 70 mg/dL — lower than most standard “normal” ranges.
  • A 2026 cohort study published in JAMA Cardiology found that elevated Lp(a) predicts 30-year cardiovascular risk in healthy individuals, yet most people have never been tested for it.
  • Blood pressure targets for adults over 40 who want longevity-level protection sit closer to 120/80 mmHg or below — not the 140/90 threshold used in many clinical guidelines, as we explain in our deep dive on blood pressure targets by age and what longevity data says.
  • A suboptimal diet was responsible for an estimated 4.06 million deaths from ischemic heart disease in 2023, according to a 2026 Global Burden of Disease analysis in Nature Medicine — making food the single most powerful lever you have.

Why Turning 40 Changes Your Cardiovascular Risk

Atherosclerosis — the slow buildup of plaque inside artery walls — doesn’t start at 60. Evidence shows it begins in your twenties and progresses silently for decades. By 40, most adults already have measurable arterial changes, even without symptoms or abnormal routine labs.

The decade between 40 and 50 is when cumulative exposure to ApoB-containing particles, elevated blood pressure, and inflammation starts crossing critical thresholds. Dr. Peter Attia, whose framework in Outlive: The Science and Art of Longevity has shaped how many physicians now approach preventive cardiology, argues this is precisely the window when aggressive prevention — not watchful waiting — saves lives.

Hormonal changes compound the risk after 40. In women, perimenopause brings declining estrogen, which removes a natural protective effect on blood vessels. In men, gradually falling testosterone correlates with worsening lipid profiles and increasing visceral fat. For a deeper look at how these shifts interact with muscle loss, our guide on muscle loss after menopause covers the downstream effects in detail.

The bottom line: your forties are not too early to care about this. They may be the most important decade for prevention.

ApoB: The Cholesterol Number That Actually Matters

ApoB (apolipoprotein B) is a protein that sits on the surface of every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a). Each of those particles carries exactly one ApoB molecule. So ApoB is essentially a direct count of the number of harmful particles in your blood.

Why does that matter? Because two people can have identical LDL cholesterol levels but very different numbers of LDL particles — and it’s the particle count that determines how often arterial walls get hit. Standard LDL measures the cholesterol content inside those particles. ApoB measures the number of particles doing the damage.

What’s the Optimal ApoB Level?

Most labs flag ApoB as “normal” below 100 mg/dL. But for adults over 40 who want longevity-level cardiovascular protection, the target is tighter. Dr. Attia and other preventive cardiologists working in the longevity space recommend aiming for ApoB below 70 mg/dL — the same target used in patients who have already had a cardiac event.

Our dedicated deep-dive at ApoB optimal range: what your number should be covers the evidence behind those cut-points in more detail.

How to Get Tested

ApoB is a simple blood test, but many standard panels don’t include it automatically. You’ll usually need to request it specifically or order it through a direct-to-consumer lab service. The test costs between $20 and $50 out of pocket in most of the US. That’s a remarkably small price for information that could change your treatment decisions significantly.

Evidence strength: Strong. Multiple large prospective studies and meta-analyses confirm ApoB outperforms LDL-C as a cardiovascular risk predictor in humans.

Lp(a): The Silent Risk Factor You’ve Probably Never Tested

Lp(a) — lipoprotein(a) — is a modified LDL particle with an extra sticky protein called apolipoprotein(a) attached to it. It’s genetically determined. Diet and exercise barely move it. And a significant minority of adults carries levels high enough to meaningfully raise their cardiovascular risk — and most of them have no idea.

Most people have never heard of it. Most doctors still don’t test for it routinely. That’s a real problem — and as we explore in our guide on dental health and longevity, overlooked risk factors like these can have far-reaching effects on cardiovascular health.

What the 2026 Research Says

A major cohort study published in JAMA Cardiology in 2026 examined 30-year cardiovascular risk trajectories in healthy women according to baseline Lp(a) levels. The finding was direct: elevated Lp(a) predicted high long-term cardiovascular risk even in individuals who appeared healthy by conventional measures. You can read the full study at PubMed (PMID 41499112).

This is a cohort study — observational in design — so it can’t prove causation the way a randomized trial does. But the association is biologically plausible, consistent across multiple large populations, and strong enough that the European Society of Cardiology recommends everyone be tested for Lp(a) at least once in their lifetime.

What Counts as High Lp(a)?

The general threshold used in cardiovascular research is 50 mg/dL (or roughly 125 nmol/L). Above that level, the risk of heart attack and aortic valve disease increases meaningfully. Some researchers argue the risk begins climbing even earlier, but 50 mg/dL is the most widely used clinical cut-point as of 2026.

For a full breakdown of what your Lp(a) result means and how to interpret it, see our guide: Is an Lp(a) blood test worth getting?

Can You Lower Lp(a)?

Honestly, not by much through lifestyle alone. Niacin (nicotinic acid) does reduce Lp(a) to a degree, but large trials — including HPS2-THRIVE and AIM-HIGH — have not shown that adding it to statin therapy translates to fewer cardiac events. A new class of drugs called RNA-targeting therapies (specifically olpasiran and pelacarsen) reduce Lp(a) by 70-95% in phase 2 and 3 trials — but as of mid-2026, none have completed the outcomes data needed for regulatory approval. This is a rapidly moving area. Watch it closely.

If your Lp(a) is high, the most actionable response right now is to drive every other risk factor — ApoB, blood pressure, inflammation, blood sugar — as low as possible. You can’t change your Lp(a) much. You can absolutely change everything around it.

Evidence strength: Strong for risk prediction (consistent across large human cohorts). Moderate for interventions — lifestyle has minimal effect; drug therapies are promising but outcomes data is pending.

Blood Pressure Targets for Longevity (Not Just “Normal”)

Here’s something worth being direct about: the threshold of 140/90 mmHg used in many clinical guidelines to define hypertension is not a longevity target. It’s a treatment trigger. Those are very different things.

The SPRINT trial, one of the most influential cardiovascular trials of the last decade, found that targeting systolic blood pressure below 120 mmHg (rather than below 140 mmHg) reduced major cardiovascular events by 25% and all-cause mortality by 27% in adults at elevated cardiovascular risk. That’s a massive effect size for a lifestyle-modifiable measurement.

What “Normal” Really Means After 40

Blood pressure increases with age in most Western populations — but that increase is not inevitable, and it’s not harmless. Each 20 mmHg rise in systolic pressure above 115 mmHg roughly doubles the risk of death from ischemic heart disease and stroke, according to a landmark meta-analysis of over one million adults published in The Lancet (Lewington et al., 2002, PMID 12493255).

For adults over 40 who want to operate at the longevity end of the spectrum, aiming for 115-120 mmHg systolic and under 80 mmHg diastolic is a reasonable goal. Getting there may require medication for some people — and that’s not a failure. It’s an acknowledgment that biology sometimes needs help.

How to Measure It Accurately

Most people measure blood pressure wrong. Common mistakes include measuring right after caffeine, exercise, or stress — or only measuring once. For accurate home readings, use a validated upper-arm cuff (not a wrist device), sit quietly for five minutes first, take three readings two minutes apart, and record the average of the last two.

White-coat hypertension — where readings are elevated only in a clinical setting — is real and well-documented; home monitoring is the most reliable way to know whether your clinic readings reflect your actual day-to-day blood pressure. Home monitoring matters.

Evidence strength: Very strong. The blood pressure-cardiovascular risk relationship is among the most replicated findings in all of medicine, supported by dozens of large human RCTs.

Diet and Heart Disease: What the 2026 Evidence Says

Diet is the most powerful modifiable lever for cardiovascular risk. Not supplements. Not expensive tests. Food.

A 2026 analysis published in Nature Medicine, using the Global Burden of Disease 2023 dataset across 204 countries, estimated that a suboptimal diet was responsible for 4.06 million deaths from ischemic heart disease in 2023 alone. The study identified specific dietary patterns — low intake of whole grains, nuts, seeds, fruits, vegetables, and omega-3 fatty acids, combined with excess sodium and trans fats — as the dominant drivers. You can explore the full data at PubMed (PMID 41912805).

What Dietary Pattern Has the Best Evidence?

The Mediterranean diet has the strongest human trial evidence for cardiovascular outcomes. The PREDIMED trial (Spain, 7,000+ participants) found that a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by approximately 30% versus a low-fat control diet. Our full breakdown in the longevity diet complete guide covers the evidence hierarchy across dietary patterns.

Key features of the highest-evidence dietary approach for heart health after 40:

  • Extra-virgin olive oil as the primary fat source (4+ tablespoons per day in PREDIMED)
  • High intake of vegetables, legumes, and whole grains
  • Fatty fish (salmon, sardines, mackerel) at least twice per week for omega-3s
  • Nuts daily — particularly walnuts
  • Minimal ultra-processed food and refined carbohydrates
  • Moderate total sodium (under 2,300 mg/day for most adults)

What About Saturated Fat?

The saturated fat debate is genuinely more complex than either “it causes heart disease” or “it’s been exonerated.” The honest answer is this: replacing saturated fat with refined carbohydrates doesn’t help. Replacing it with unsaturated fats from olive oil, nuts, and avocado probably does. The type of replacement matters more than whether you restrict saturated fat at all.

Saturated fat raises both LDL cholesterol and ApoB in most people. For someone already working to bring ApoB below 70 mg/dL, moderating saturated fat (red meat, butter, full-fat dairy in large quantities) is a reasonable tool to deploy — not a dogmatic rule, but a practical lever.

Exercise for Cardiovascular Longevity: The Evidence-Based Protocol

Cardiorespiratory fitness (VO2 max) is, per available evidence, the single strongest predictor of longevity. Not ApoB. Not blood pressure. Not grip strength — though all of those matter. Research consistently shows that adults with the lowest cardiorespiratory fitness for their age carry dramatically higher mortality risk than those at the top — a gap larger than almost any other single risk factor measured in the same populations.

Our piece on VO2 max as a longevity predictor makes this case in detail. Here’s what the research says you should do.

Zone 2 Training: The Foundation

Zone 2 cardio — steady-state aerobic exercise at roughly 60-70% of maximum heart rate — builds mitochondrial density, improves metabolic flexibility, and drives down resting blood pressure over time. Dr. Attia’s publicly documented framework — laid out in Outlive and across his podcast — calls for roughly 180 minutes or more of Zone 2 per week as a baseline for adults over 40, though the right volume for you depends on your current fitness and schedule.

To calculate your Zone 2 range accurately by age, see our guide on Zone 2 heart rate by age. The formulas differ, and getting this wrong means you’re probably working too hard or not hard enough.

High-Intensity Intervals: The VO2 Max Driver

Zone 2 builds the aerobic base. High-intensity interval training (HIIT) raises the ceiling. Research supports 1-2 sessions per week of interval training — typically 4-6 bouts of 3-4 minutes at near-maximal effort with equivalent recovery periods — as the most time-efficient method to increase VO2 max in adults.

These sessions are hard. But the mortality data suggests the effort is worth it.

Strength Training: The Under-Appreciated Piece

Muscle mass is metabolically protective. Resistance training improves insulin sensitivity, reduces visceral fat, and independently predicts cardiovascular survival. The evidence for strength training’s role in longevity is genuinely overwhelming — we cover it extensively in Strength Training for Longevity.

The practical minimum for cardiovascular benefit: two resistance training sessions per week targeting major muscle groups.

Evidence strength: Very strong. The exercise-cardiovascular mortality relationship is among the most replicated in epidemiology, with multiple large RCTs confirming mechanistic pathways.

Supplements and Medications: What’s Worth It?

Let’s be honest about what supplements can and can’t do for heart health. None of them replicate the effect size of diet, exercise, or — where needed — medication. But a few have real human evidence behind them.

Omega-3 Fatty Acids

The evidence for omega-3s is mixed and dose-dependent. At low doses (1g/day), large trials have been disappointing for cardiovascular endpoints. At high doses of EPA specifically (4g/day prescription-strength icosapentaenoic acid, as used in the REDUCE-IT trial), a 25% relative reduction in cardiovascular events was seen in patients with elevated triglycerides already on statins. That’s a specific population and a specific formulation.

For most healthy adults, optimizing dietary omega-3 intake through fatty fish and tracking your omega-3 index is the right starting point. Our guide on omega-3 index optimal levels explains how to test yours and what to target.

Magnesium

Magnesium deficiency is common in adults over 40 and correlates with higher blood pressure, worse insulin sensitivity, and greater inflammation. Supplementation in people who are deficient modestly reduces blood pressure, according to multiple published meta-analyses — a real effect, though not a large one, and most meaningful when deficiency is confirmed by a blood test. That’s not dramatic, but it’s real and safe.

Statins and Other Medications

Statins are the most evidence-backed pharmacological intervention for reducing ApoB and cardiovascular events. If your ApoB is above 70 mg/dL after diet optimization and your 10-year cardiovascular risk is elevated, statins are worth a serious conversation with your doctor — not dismissal. The side-effect concerns, while real for some, are substantially overstated in public discourse relative to the benefits.

For people whose ApoB remains high despite statins, PCSK9 inhibitors (injectable biologics) drive ApoB meaningfully lower — the degree of reduction depends on the individual and the agent, and your prescribing physician can walk you through what the trial data shows for your situation. They’re expensive, but for high-risk individuals they’re genuinely effective.

What About NAD+ Precursors?

There’s interesting mechanistic research connecting NAD+ availability to endothelial function and cardiovascular aging. But as of 2026, the human evidence for NAD+ precursors specifically improving cardiovascular outcomes is preliminary. Our complete NAD+ and NMN guide covers what’s established versus what’s still speculative.

Evidence strength for supplements: Moderate for high-dose EPA omega-3s in specific populations. Weak-to-moderate for magnesium. Insufficient for most other supplements as primary cardiovascular interventions in healthy adults.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only recommend products we genuinely believe in. Learn more.

What We Recommend

  • Outlive: The Science and Art of Longevity — Dr. Peter Attia. The most practically useful book on cardiovascular prevention written for non-physicians. Dr. Attia’s framework for understanding ApoB, Lp(a), blood pressure, and exercise as a unified system is worth more than most cardiology appointments.
  • Tru Niagen (NAD+ Precursor — NR). If you’re addressing cardiovascular aging comprehensively, maintaining NAD+ levels supports mitochondrial function and vascular health. Tru Niagen is the most-studied NR supplement, used in multiple human clinical trials — a reasonable addition to a broader longevity protocol.

Your Complete Heart Health Protocol After 40

Everything above is useful only if it changes what you actually do. Here’s a concrete protocol, organized by the highest-leverage actions first.

Step 1: Get the Right Tests

At your next physical, request these specific tests if they’re not on your standard panel — and consider adding a coronary calcium score to get a direct picture of plaque buildup in your arteries:

  • ApoB — target below 70 mg/dL for longevity-level protection
  • Lp(a) — test once; it’s largely genetic and doesn’t need repeat testing
  • Fasting insulin and glucose — to assess insulin resistance, which compounds cardiovascular risk significantly
  • hsCRP (high-sensitivity C-reactive protein) — a marker of vascular inflammation; what level to target is a conversation with your clinician based on your full risk picture
  • Omega-3 index — testing this tells you where you stand; what to target is worth discussing with your doctor alongside your other cardiovascular markers

Step 2: Establish Your Blood Pressure Baseline

Measure at home over seven days, twice daily (morning and evening), and average the results. If your average systolic is above 130 mmHg, address it — through diet, sodium reduction, exercise, stress management, or medication if needed. Don’t accept 135 as fine. It isn’t, by longevity standards.

Step 3: Optimize Diet Around What Has the Most Evidence

  • Increase extra-virgin olive oil as primary cooking fat
  • Eat fatty fish at least twice a week
  • Add a daily handful of mixed nuts
  • Reduce ultra-processed food and refined carbohydrates to less than 10% of calories
  • Keep sodium under 2,300 mg/day, or under 1,500 mg if blood pressure is already elevated

Step 4: Build Your Exercise Foundation

  • Aim for 150-200 minutes of Zone 2 cardio per week minimum
  • Add 1-2 HIIT sessions per week to drive VO2 max improvement
  • Include 2 resistance training sessions targeting major muscle groups
  • Track your resting heart rate and blood pressure monthly as objective markers of progress

Step 5: Revisit Annually

Cardiovascular risk isn’t static. Retest ApoB and hsCRP annually. If ApoB isn’t moving toward target after 3-6 months of diet changes, have a direct conversation about medication. Statins, when appropriate, have a better evidence base than almost any supplement on the market.

You can track this alongside broader longevity biomarkers using the framework in our complete guide to longevity biomarkers to track in 2026.

Medical Disclaimer: The content on The Longevity Dose is for informational and educational purposes only. It is not medical advice and should not replace consultation with a qualified healthcare provider. Always speak with your doctor before starting any new supplement, exercise, or health protocol, especially if you have an existing medical condition or take medications. Read our full health disclaimer.

Frequently Asked Questions

What is the difference between ApoB and LDL cholesterol?

LDL cholesterol measures the amount of cholesterol carried inside LDL particles. ApoB measures the total number of atherogenic lipoprotein particles in the blood, including LDL, VLDL, and Lp(a). Because each particle carries exactly one ApoB molecule, ApoB is a more direct and accurate count of the particles that cause arterial damage. Two people with the same LDL level can have very different ApoB levels — and very different cardiovascular risk as a result.

Should everyone over 40 get their Lp(a) tested?

Yes, and most cardiologists and longevity physicians now agree on this. The European Society of Cardiology recommends a one-time Lp(a) test for all adults. A 2026 cohort study in JAMA Cardiology confirmed that elevated Lp(a) predicts 30-year cardiovascular risk in apparently healthy individuals. Since Lp(a) is genetically determined and barely changes over a lifetime, you only need to test it once — but you do need to know the number.

What blood pressure should I aim for after 40?

For longevity-level protection, aim for systolic blood pressure below 120 mmHg and diastolic below 80 mmHg. The SPRINT trial found that targeting below 120 mmHg (vs. below 140 mmHg) reduced major cardiovascular events by 25% and all-cause mortality by 27%. The 140/90 threshold used in many guidelines is a treatment trigger, not an optimal target.

Can diet alone bring ApoB to an optimal level?

For some people, yes. Replacing saturated fat with unsaturated fats, reducing refined carbohydrates, increasing fiber, and losing visceral fat can all move ApoB in the right direction — how much depends on your starting point, your genetics, and how consistently the changes are applied. However, many adults have genetically driven elevated ApoB that diet alone can’t normalize. If your ApoB remains above 70 mg/dL after consistent dietary changes, statins or other lipid-lowering medications are a reasonable next step — not a last resort.

What is the most important exercise for heart health after 40?

Cardiorespiratory fitness — specifically VO2 max — is the strongest exercise-related predictor of cardiovascular mortality. Zone 2 aerobic training (roughly 150-200 minutes per week) builds the aerobic base, while 1-2 weekly high-intensity interval sessions drive VO2 max improvements. Resistance training adds metabolic and structural cardiovascular benefits. Combining all three is the evidence-based approach.

Are there any supplements proven to improve heart health?

High-dose EPA omega-3s (4g/day prescription-strength icosapentaenoic acid) showed a 25% reduction in cardiovascular events in the REDUCE-IT trial, but in a specific population: patients with elevated triglycerides already on statins. Magnesium supplementation modestly reduces blood pressure in deficient individuals. Most other supplements marketed for heart health lack the human trial evidence to support meaningful cardiovascular outcome claims as of 2026.

Liked This? Keep Reading.

Get the next post in your inbox. Real science on longevity, supplements, and fitness — no hype.

Drop your email below. Weekly. No spam. Unsubscribe anytime. ↓

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *